The methylation analysis revealed a significant association of SEMA3B hypermethylation with tumor progression in terms of tumor stage and grade for both subtypes of NSCLC (SCC and ADC) and ccRCC. The gene discussed is SEMA3B; the disease is nonpapillary renal cell carcinoma.